UC San Diego study reveals that toxin?related chronic rhinosinusitis shows a two?fold rise in sinus mast cells, pointing to a new therapeutic target for veterans and others exposed to smoke airway risk factor.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
